The discovery of ezetimibe: A view from outside the receptor

被引：263

作者：

Clader, JW ^{[1
]}

机构：

[1] Schering Plough Res Inst, Cardiovasc & CNS Med Chem Dept, Kenilworth, NJ 07033 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 01期

关键词：

D O I：

10.1021/jm030283g

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1 / 9

页数：9

共 43 条

[31]

Shankar, 1999, Patent No. [5856473A, 5856473]

[32] Synthesis of an optically pure 3-unsubstituted beta-lactam using an asymmetric Reformatsky reaction and its conversion to cholesterol absorption inhibitors [J].

Shankar, BB ;

Kirkup, MP ;

McCombie, SW ;

Clader, JW ;

Ganguly, AK .

TETRAHEDRON LETTERS, 1996, 37 (24) :4095-4098

[33]

SLISKOVIC DR, 1991, TRENDS PHARMACOL SCI, V323, P1289

[34]

Sliskovic Drago R, 2002, Prog Med Chem, V39, P121, DOI 10.1016/S0079-6468(08)70070-5

[35]

Strader CD, 1996, J MED CHEM, V39, P1

[36]

THIRUVENGADAM TK, 2000, Patent No. 0034240

[37] Inhibitors of acyl CoA:cholesterol acyltransferase [J].

Vaccaro, W ;

Amore, C ;

Berger, J ;

Burrier, R ;

Clader, J ;

Davis, H ;

Domalski, M ;

Fevig, T ;

Salisbury, B ;

Sher, R .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) :1704-1719

[38]

VanHeek M, 1997, J PHARMACOL EXP THER, V283, P157

[39]

WEINER D, 1995, CHEM STRUCTURAL APPR

[40]

WEINER DB, 1995, BIOL APPROACHES RATI

← 1 2 3 4 5 →